|
1
|
Onciu M: Acute lymphoblastic leukemia.
Hematol Oncol Clin North Am. 23:655–674. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rouce RH, Shaim H, Sekine T, Weber G,
Ballard B, Ku S, Barese C, Murali V, Wu MF, Liu H, et al: The
TGF-β/SMAD pathway is an important mechanism for NK cell immune
evasion in childhood B-acute lymphoblastic leukemia. Leukemia.
30:800–811. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Oelsner S, Wagner J, Friede ME, Pfirrmann
V, Genßler S, Rettinger E, Buchholz CJ, Pfeifer H, Schubert R,
Ottmann OG, et al: Chimeric antigen receptor-engineered
cytokine-induced killer cells overcome treatment resistance of
pre-B-cell acute lymphoblastic leukemia and enhance survival. Int J
Cancer. 139:1799–1809. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miller JS, Soignier Y,
Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, McKenna
D, Le C, Defor TE, Burns LJ, et al: Successful adoptive transfer
and in vivo expansion of human haploidentical NK cells in
patients with cancer. Blood. 105:3051–3057. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pende D, Spaggiari GM, Marcenaro S,
Martini S, Rivera P, Capobianco A, Falco M, Lanino E, Pierri I,
Zambello R, et al: Analysis of the receptor-ligand interactions in
the natural killer-mediated lysis of freshly isolated myeloid or
lymphoblastic leukemias: Evidence for the involvement of the
Poliovirus receptor (CD155) and Nectin-2 (CD112). Blood.
105:2066–2073. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Romanski A, Bug G, Becker S, Kampfmann M,
Seifried E, Hoelzer D, Ottmann OG and Tonn T: Mechanisms of
resistance to natural killer cell-mediated cytotoxicity in acute
lymphoblastic leukemia. Exp Hematol. 33:344–352. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sanchez-Correa B, Morgado S, Gayoso I,
Bergua JM, Casado JG, Arcos MJ, Bengochea ML, Duran E, Solana R and
Tarazona R: Human NK cells in acute myeloid leukaemia patients:
Analysis of NK cell-activating cellactivating receptors and their
ligands. Cancer Immunol Immunother. 60:1195–1205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lion E, Willemen Y, Berneman ZN, Van
Tendeloo VF and Smits EL: Natural killer cell immune escape in
acute myeloid leukemia. Leukemia. 26:2019–2026. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chiossone L, Chaix J, Fuseri N, Roth C,
Vivier E and Walzer T: Maturation of mouse NK cells is a 4-stage
developmental program. Blood. 113:5488–5496. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hayakawa Y and Smyth MJ: CD27 dissects
mature NK cells into two subsets with distinct responsiveness and
migratory capacity. J Immunol. 176:1517–1524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cooper MA, Fehniger TA, Turner SC, Chen
KS, Ghaheri BA, Ghayur T, Carson WE and Caligiuri MA: Human natural
killer cells: A unique innate immunoregulatory role for the CD56
(bright) subset. Blood. 97:3146–3151. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu J, Freud AG and Caligiuri MA: Location
and cellular stages of natural killer cell development. Trends
Immunol. 34:573–582. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Caligiuri MA: Human natural killer cells.
Blood. 112:461–469. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chan A, Hong DL, Atzberger A, Kollnberger
S, Filer AD, Buckley CD, McMichael A, Enver T and Bowness P:
CD56bright human NK cells differentiate into CD56dim cells: Role of
contact with peripheral fibroblasts. J Immunol. 179:89–94. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin F, Lin H, Gao S, Hu Z, Zuo S, Sun L,
Jin C, Li W and Yang Y: The anti-tumor role of NK cells in vivo
pre-activated and re-stimulated by interleukins in acute
lymphoblastic leukemia. Oncotarget. 7:79187–79202. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu J, Song Y, Bakker AB, Bauer S, Spies T,
Lanier LL and Phillips JH: An activating immunoreceptor complex
formed by NKG2D and DAP10. Science. 285:730–732. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mundy-Bosse BL, Scoville SD, Chen L,
McConnell K, Mao HC, Ahmed EH, Zorko N, Harvey S, Cole J, Zhang X,
et al: MicroRNA-29b mediates altered innate immune development in
acute leukemia. J Clin Invest. 126:4404–4416. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Leong JW, Sullivan RP and Fehniger TA:
MicroRNA management of NK-cell developmental and functional
programs. Eur J Immunol. 44:2862–2868. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weng AP, Ferrando AA, Lee W, Morris JP IV,
Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT and Aster
JC: Activating mutations of NOTCH1 in human T cell acute
lymphoblastic leukemia. Science. 306:269–271. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kloss M, Decker P, Baltz KM, Baessler T,
Jung G, Rammensee HG, Steinle A, Krusch M and Salih HR: Interaction
of monocytes with NK cells upon Toll-like receptor-induced
expression of the NKG2D ligand MICA. J Immunol. 181:6711–6719.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang Y, Wang H, Yu H, Yeap BY, Liang T,
Wang G, Cheng T and Yang YG: IFN-γ promotes graft-versus-leukemia
effects without directly interacting with leukemia cells in mice
after allogeneic hematopoietic cell transplantation. Blood.
118:3721–3724. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lieberman NAP, DeGolier K, Haberthur K,
Chinn H, Moyes KW, Bouchlaka MN, Walker KL, Capitini CM and Crane
CA: An uncoupling of canonical phenotypic markers and functional
potency of ex vivo-expanded natural killer cells. Front Immunol.
9:1502018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Garzon R, Heaphy CE, Havelange V, Fabbri
M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA,
et al: MicroRNA 29b functions in acute myeloid leukemia. Blood.
114:5331–5341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu S, Wu LC, Pang J, Santhanam R, Schwind
S, Wu YZ, Hickey CJ, Yu J, Becker H, Maharry K, et al:
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid
leukemia. Cancer Cell. 17:333–347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huan J, Hornick NI, Shurtleff MJ, Skinner
AM, Goloviznina NA, Roberts CT Jr and Kurre P: RNA trafficking by
acute myelogenous leukemia exosomes. Cancer Res. 73:918–929. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boukouaci W, Al-Daccak R, Dulphy N, Lauden
L, Amokrane K, Fortier C, Marzais F, Bennabi M, Peffault de Latour
R, Socie G, et al: Soluble MICA-NKG2D interaction upregulates IFN-γ
production by activated CD3-CD56+ NK cells: Potential impact on
chronic graft versus host disease. Hum Immunol. 74:1536–1541. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boieri M, Ulvmoen A, Sudworth A, Lendrem
C, Collin M, Dickinson AM, Kveberg L and Inngjerdingen M: IL-12,
IL-15, and IL-18 pre-activated NK cells target resistant T cell
acute lymphoblastic leukemia and delay leukemia development in
vivo. Oncoimmunology. 6:e12744782017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Steiner DF, Thomas MF, Hu JK, Yang Z,
Babiarz JE, Allen CD, Matloubian M, Blelloch R and Ansel KM:
MicroRNA-29 regulates T-box transcription factors and interferon-γ
production in helper T cells. Immunity. 35:169–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Smith KM, Guerau-de-Arellano M, Costinean
S, Williams JL, Bottoni A, Mavrikis Cox G, Satoskar AR, Croce CM,
Racke MK, Lovett-Racke AE and Whitacre CC: miR-29ab1 deficiency
identifies a negative feedback loop controlling Th1 bias that is
dysregulated in multiple sclerosis. J Immunol. 189:1567–1576. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gordon SM, Chaix J, Rupp LJ, Wu J, Madera
S, Sun JC, Lindsten T and Reiner SL: The transcription factors
T-bet and Eomes control key checkpoints of natural killer cell
maturation. Immunity. 36:55–67. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yeh YY, Ozer HG, Lehman AM, Maddocks K, Yu
L, Johnson AJ and Byrd JC: Characterization of CLL exosomes reveals
a distinct microRNA signature and enhanced secretion by activation
of BCR signaling. Blood. 125:3297–3305. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Whiteside TL: Immune modulation of T-cell
and NK (natural killer) cell activities by TEXs (tumour-derived
exosomes). Biochem Soc Trans. 41:245–251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dauguet N, Récher C, Demur C, Fournié JJ,
Poupot M and Poupot R: Pre-eminence and persistence of immature
natural killer cells in acute myeloid leukemia patients in first
complete remission. Am J Hematol. 86:209–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Smyth MJ, Cretney E, Kelly JM, Westwood
JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti
MA and Hayakawa Y: Activation of NK cell cytotoxicity. Mol Immunol.
42:501–510. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wallach D, Fellous M and Revel M:
Preferential effect of gamma interferon on the synthesis of HLA
antigens and their mRNAs in human cells. Nature. 299:833–836. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maher SG, Romero-Weaver AL, Scarzello AJ
and Gamero AM: Interferon: Cellular executioner or white knight?
Curr Med Chem. 14:1279–1289. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jelenčić V, Lenartić M, Wensveen FM and
Polić B: NKG2D: A versatile player in the immune system. Immunol
Lett. 189:48–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Moretta A, Bottino C, Vitale M, Pende D,
Cantoni C, Mingari MC, Biassoni R and Moretta L: Activating
receptors and coreceptors involved in human natural killer
cell-mediated cytolysis. Annu Rev Immunol. 19:197–223. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mistry AR and O'Callaghan CA: Regulation
of ligands for the activating receptor NKG2D. Immunology.
121:439–447. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Girart MV, Fuertes MB, Domaica CI, Rossi
LE and Zwirner NW: Engagement of TLR3, TLR7, and NKG2D regulate
IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK
cells stimulated with suboptimal doses of IL-12. J Immunol.
179:3472–3479. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim JY, Huh K, Lee KY, Yang JM and Kim TJ:
Nickel induces secretion of IFN-gamma by splenic natural killer
cells. Exp Mol Med. 41:288–295. 2009. View Article : Google Scholar : PubMed/NCBI
|
